These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 8024040
21. Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase. MaassenVanDenBrink A, de Vries R, Saxena PR, Schalekamp MA, Danser AH. Cardiovasc Res; 1999 Nov; 44(2):407-15. PubMed ID: 10690317 [Abstract] [Full Text] [Related]
22. Primacy of cardiac chymase over angiotensin converting enzyme as an angiotensin-(1-12) metabolizing enzyme. Ahmad S, Varagic J, VonCannon JL, Groban L, Collawn JF, Dell'Italia LJ, Ferrario CM. Biochem Biophys Res Commun; 2016 Sep 16; 478(2):559-64. PubMed ID: 27465904 [Abstract] [Full Text] [Related]
23. Role of elastase-2 as an angiotensin II-forming enzyme in rat carotid artery. Becari C, Sivieri DO, Santos CF, Moysés MK, Oliveira EB, Salgado MC. J Cardiovasc Pharmacol; 2005 Oct 16; 46(4):498-504. PubMed ID: 16160604 [Abstract] [Full Text] [Related]
24. Selectivity of converting-enzyme inhibitors for angiotensin I versus bradykinin hydrolysis reactions. Brooks RR, Miller KE, Jones SM, Burns RH, Huang CT. J Pharm Sci; 1990 May 16; 79(5):384-8. PubMed ID: 2161922 [Abstract] [Full Text] [Related]
28. Regulation of local angiotensin II formation in the human heart in the presence of interstitial fluid. Inhibition of chymase by protease inhibitors of interstitial fluid and of angiotensin-converting enzyme by Ang-(1-9) formed by heart carboxypeptidase A-like activity. Kokkonen JO, Saarinen J, Kovanen PT. Circulation; 1997 Mar 18; 95(6):1455-63. PubMed ID: 9118513 [Abstract] [Full Text] [Related]
29. Converting enzyme activity and angiotensin metabolism in the dog brainstem. Santos RA, Brosnihan KB, Chappell MC, Pesquero J, Chernicky CL, Greene LJ, Ferrario CM. Hypertension; 1988 Feb 18; 11(2 Pt 2):I153-7. PubMed ID: 2831145 [Abstract] [Full Text] [Related]
32. Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction. van Esch JH, Tom B, Dive V, Batenburg WW, Georgiadis D, Yiotakis A, van Gool JM, de Bruijn RJ, de Vries R, Danser AH. Hypertension; 2005 Jan 18; 45(1):120-5. PubMed ID: 15583077 [Abstract] [Full Text] [Related]
33. [Protective effect of an angiotensin-converting-enzyme inhibitor on neurogenic pulmonary edema in rabbits]. Chen Y, Song F, Lu G, Lu Z. Zhonghua Er Ke Za Zhi; 2014 Aug 18; 52(8):602-6. PubMed ID: 25224238 [Abstract] [Full Text] [Related]
35. Angiotensin II formation in dog heart is mediated by different pathways in vivo and in vitro. Balcells E, Meng QC, Hageman GR, Palmer RW, Durand JN, Dell'Italia LJ. Am J Physiol; 1996 Aug 18; 271(2 Pt 2):H417-21. PubMed ID: 8770078 [Abstract] [Full Text] [Related]
39. Different modulation of steroidogenesis and prostaglandin production in frog ovary in vitro by ACE and ANG II. Bramucci M, Miano A, Gobbetti A, Zerani M, Quassinti L, Maccari E, Murri O, Amici D. Am J Physiol; 1997 Dec 18; 273(6):R2089-96. PubMed ID: 9435665 [Abstract] [Full Text] [Related]